Novo Nordisk Says New Obesity Drug Helps Patients Lose Weight in Mid-Stage Trial

The pharma giant said amycretin led to weight loss and diabetes reductions in both injection and pill versions.

Novo Nordisk’s weight-loss-drug trial provides rare good news in a rocky year

Novo Nordisk, whose shares have stumbled this year, on Tuesday announced a positive trial result for a weight-loss drug in ...
HealthDay on MSN

GLP-1 Weight-Loss Drug in Pill Form Shows Promise in Trial

Key Takeaways Current GLP-1 weight-loss meds need to be taken as injections, but new trial results suggest a GLP-1 in pill ...

Novo Nordisk's obesity drug shows weight loss of up to 14.5% in mid-stage study

Novo Nordisk said on Tuesday its experimental obesity drug, amycretin, showed statistically significant weight loss of up to 14.5% at 36 weeks in patients with type 2 diabetes in a mid-stage study.

Weight-Loss Drugs Don’t Appear to Work Against Alzheimer’s

GLP-1 drugs like Wegovy and Zepbound have been racking up sales and new indications, as researchers learn more about how the ...
KJZZ

5 things to know about the new obesity pills that are on the way

Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the ...
SHEfinds on MSN

Ariana Grande Fans ‘Worried’ After Noticing Her Weight Loss During Wicked: For Good Promo Appearance

Ariana Grande Red Carpet Grabber Deported, Banned From Singapore Six-figure earners are ‘living the illusion of affluence’ ...

Voting Results: Mason Coleman named The Sporting News Louisiana high school football performer from Week 1 of the playoffs (Nov. 10-16)

Mason Coleman had a huge night on defense for his team in its opening-round playoff game. A junior defensive ...